NKGen Biotech (NKGN) Competitors $0.64 +0.07 (+13.25%) (As of 12/20/2024 05:31 PM ET) Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrends NKGN vs. INCR, ONCY, CUE, BYSI, VNRX, ATRA, CNTB, SPRO, AADI, and MURAShould you be buying NKGen Biotech stock or one of its competitors? The main competitors of NKGen Biotech include InterCure (INCR), Oncolytics Biotech (ONCY), Cue Biopharma (CUE), BeyondSpring (BYSI), VolitionRx (VNRX), Atara Biotherapeutics (ATRA), Connect Biopharma (CNTB), Spero Therapeutics (SPRO), Aadi Bioscience (AADI), and Mural Oncology (MURA). These companies are all part of the "pharmaceutical products" industry. NKGen Biotech vs. InterCure Oncolytics Biotech Cue Biopharma BeyondSpring VolitionRx Atara Biotherapeutics Connect Biopharma Spero Therapeutics Aadi Bioscience Mural Oncology InterCure (NASDAQ:INCR) and NKGen Biotech (NYSE:NKGN) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, media sentiment, community ranking, dividends and earnings. Which has better earnings & valuation, INCR or NKGN? InterCure has higher revenue and earnings than NKGen Biotech. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioInterCure$272.67M0.25-$16.83MN/AN/ANKGen Biotech$80K282.90-$82.94M-$5.08-0.13 Is INCR or NKGN more profitable? Company Net Margins Return on Equity Return on Assets InterCureN/A N/A N/A NKGen Biotech N/A N/A -479.36% Do institutionals and insiders have more ownership in INCR or NKGN? 8.3% of InterCure shares are owned by institutional investors. Comparatively, 76.2% of NKGen Biotech shares are owned by institutional investors. 0.2% of InterCure shares are owned by insiders. Comparatively, 74.7% of NKGen Biotech shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth. Does the MarketBeat Community prefer INCR or NKGN? InterCure received 3 more outperform votes than NKGen Biotech when rated by MarketBeat users. CompanyUnderperformOutperformInterCureOutperform Votes3100.00% Underperform VotesNo VotesNKGen BiotechN/AN/A Which has more risk & volatility, INCR or NKGN? InterCure has a beta of 1.37, indicating that its share price is 37% more volatile than the S&P 500. Comparatively, NKGen Biotech has a beta of 0.77, indicating that its share price is 23% less volatile than the S&P 500. Does the media favor INCR or NKGN? In the previous week, InterCure had 2 more articles in the media than NKGen Biotech. MarketBeat recorded 2 mentions for InterCure and 0 mentions for NKGen Biotech. InterCure's average media sentiment score of 0.00 equaled NKGen Biotech'saverage media sentiment score. Company Overall Sentiment InterCure Neutral NKGen Biotech Neutral SummaryInterCure beats NKGen Biotech on 6 of the 9 factors compared between the two stocks. Ad DTICackling Kamala hates this companyDo you want to see one of the most exciting election trades of all time? A trade that could help America become 100% energy independent… Reduce energy costs to virtually zero… And hand investors what could be a stunning return in just a few years’ time? It all has to do with a little known company that is helping to kick off the next great American energy revolution. Before that happens, you need to see the details here. Get NKGen Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for NKGN and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NKGN vs. The Competition Export to ExcelMetricNKGen BiotechBiological Products IndustryMedical SectorNYSE ExchangeMarket Cap$22.63M$2.94B$5.12B$19.18BDividend YieldN/A1.90%4.91%3.59%P/E Ratio-0.1346.7391.3441.28Price / Sales282.90411.851,116.5917.59Price / CashN/A182.1042.6421.28Price / Book-0.243.894.795.32Net Income-$82.94M-$42.21M$120.07M$989.88M7 Day Performance28.05%-2.14%-1.89%-3.54%1 Month Performance89.57%4.21%11.45%-3.68%1 Year Performance-77.39%18.40%30.61%12.14% NKGen Biotech Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NKGNNKGen BiotechN/A$0.64+13.3%N/A-78.2%$22.63M$80,000.00-0.13N/AGap UpINCRInterCure0.1035 of 5 stars$1.42+7.8%N/A+16.4%$64.71M$272.67M0.00350News CoverageGap UpONCYOncolytics Biotech1.9125 of 5 stars$0.83+1.4%$4.00+384.8%-33.0%$63.58MN/A0.0030News CoverageCUECue Biopharma4.687 of 5 stars$1.00+6.4%$5.00+400.0%-63.1%$63.36M$9.53M-1.0360News CoveragePositive NewsBYSIBeyondSpringN/A$1.60-2.7%N/A+72.8%$62.25M$1.88M0.0080Positive NewsGap DownVNRXVolitionRx1.7492 of 5 stars$0.67+18.6%$3.75+459.7%+2.4%$62.09M$770,000.00-1.5780Gap UpATRAAtara Biotherapeutics3.8375 of 5 stars$10.68+3.4%$16.67+56.1%-17.6%$61.52M$100.44M-0.40165Analyst ForecastNews CoverageGap UpCNTBConnect Biopharma3.4741 of 5 stars$1.08-3.4%$8.00+640.7%+11.9%$59.68M$24.12M0.00110Positive NewsGap DownSPROSpero Therapeutics4.5453 of 5 stars$1.09+1.9%$5.00+358.7%-29.3%$59.43M$103.78M15.2946Analyst DowngradeNews CoverageAADIAadi Bioscience1.6265 of 5 stars$2.37-1.7%$1.67-29.7%+64.6%$58.41M$25.07M-1.0640News CoverageGap UpMURAMural Oncology3.0856 of 5 stars$3.41-6.3%$16.00+369.2%-9.1%$58.04MN/A-0.40119Negative NewsGap Up Related Companies and Tools Related Companies InterCure Alternatives Oncolytics Biotech Alternatives Cue Biopharma Alternatives BeyondSpring Alternatives VolitionRx Alternatives Atara Biotherapeutics Alternatives Connect Biopharma Alternatives Spero Therapeutics Alternatives Aadi Bioscience Alternatives Mural Oncology Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NYSE:NKGN) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding NKGen Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share NKGen Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.